CAS 1305267-37-1

Formula: C26H27FN4O5S

InChI: InChI=1S/C26H27FN4O5S/c27-22-3-1-2-20-24-21(17-37(33,34)25(20)22)23(26(32)30-10-14-36-15-11-30)28-31(24)19-6-4-18(5-7-19)16-29-8-12-35-13-9-29/h1-7H,8-17H2

InChI key: NFHSJYKXENYICE-UHFFFAOYSA-N

SMILES: C1COCCN1CC2=CC=C(C=C2)N3C4=C(CS(=O)(=O)C5=C4C=CC=C5F)C(=N3)C(=O)N6CCOCC6

MSC2360844

CAS: 1305267-37-1

MSC2360844

Formula: C₂₆H₂₇FN₄O₅S

Purity: 99.5%

Molecular weight: 526.58

Ref: 54-BUP16245

(6-Fluoro-1-(4-(morpholinomethyl)phenyl)-5,5-dioxido-1,4-dihydrothiochromeno[4,3-c]pyrazol-3-yl)(morpholino)methanone

CAS: 1305267-37-1

Formula: C₂₆H₂₇FN₄O₅S

Purity: 98%

Molecular weight: 526.5798

Ref: IN-DA01V3P6

Roginolisib

CAS: 1305267-37-1

(6-Fluoro-1-(4-(morpholinomethyl)phenyl)-5,5-dioxido-1,4-dihydrothiochromeno[4,3-c]pyrazol-3-yl)(morpholino)methanone

Formula: C₂₆H₂₇FN₄O₅S

Purity: 98%

Molecular weight: 526.58

Ref: IN-DG01256766

MSC2360844

CAS: 1305267-37-1

MSC2360844 is a Chinese medicinal analog that has shown potent anticancer activity against various types of tumors. It functions as an inhibitor of kinases, which are proteins involved in cell signaling and growth regulation. MSC2360844 induces apoptosis, or programmed cell death, in cancer cells by inhibiting the activity of specific kinases. This inhibitor has been shown to be effective against multiple cancer cell lines and has potential therapeutic applications for the treatment of cancer. MSC2360844 is excreted through urine after administration and shows promising results in preclinical studies as a potential anticancer agent.

Formula: C₂₆H₂₇FN₄O₅S

Purity: Min. 95%

Molecular weight: 526.6 g/mol

Ref: 3D-FCC26737

MSC2360844

CAS: 1305267-37-1

MSC2360844 is a potent, orally active and selective inhibitor of PI3Kδ(IC50 of 145 nM).

Formula: C₂₆H₂₇FN₄O₅S

Purity: 99.54% - 99.9%

Color and Shape: Solid

Molecular weight: 526.58

Ref: TM-T12115